Current best practices and rationalistic perspectives in causation-based prevention, early detection and multidisciplinary treatment of breast and gastric cancer

Gastric & Breast Cancer e-journal
DOI: 10.2122/gbc.2020.0294


Promising efficacy of targeted drugs combination in BASKET trials for advanced colorectal cancer.

Dr. John Spiliotis, MD.


The new BASKET design of clinical trials represents a smart solution to overcome modest and temporary efficacy of a single anti-EGFR or anti-VEGF drug in advanced unresectable colorectal cancers.
The validity and low cost of targeted Next Generation sequencing (tNGS) to explore known gene panels with matched approved drugs for other cancer types has recently provided promising progression-free and overall survival rates for early-phase recent clinical trials. Advances and challenges in combination of drugs targeting specific genetic mutations and supportive immunotherapy are discussed.

(Citation: Gastric & Breast Cancer 2020; 15(1): 31-36)

You can have an online full-text access and a PDF of this article:
  • Either purchase this paper for €35 EUR. Please, click here
Please specify DOI of article
  • Or through one year subscription PayPal

Online ISSN : 1109 - 7647
Print ISSN : 1109 - 7655

We subscribe to the HONcode principles of the HON Foundation. Click to verify. We subscribe to the HONcode principles. Verify here.
please, read our policy about privacy and confidentiality of information and transparency of sponsorship

last update: 15 January 2020